The Real-World Evidence Consortium for Sickle Cell Disease will develop consensus on how to use data collected from electronic health records for research and to improve care (WASHINGTON, April 17, 2024) –The ASH Research Collaborative (ASH RC) and t...

Dr. Jorge Cortes will lead new journal focused on global hematology research (WASHINGTON, April 16, 2024) — The American Society of Hematology (ASH) has selected Jorge Cortes, MD, to serve as the inaugural editor-in-chief of the newest addition...

Three-Year Survival Similar in Patients Who Did or Did Not Continue Hematology Check-Ups (WASHINGTON, April 4, 2024) – A study published in Blood Advances showed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (...

Study confirms use of EEG as a diagnostic tool and questions necessity of other diagnostic tests (WASHINGTON, March 19, 2024) – Magnetic resonance imaging (MRI) and lumbar puncture (LP) may not always be necessary for diagnosing and managing a...

Analysis reveals that T-cell malignancies accounted for 0.1% of reports submitted to FDA following CAR T-cell therapy   (WASHINGTON, March 14, 2024) – An analysis published today in Blood found that secondary cancers following C...

Reps. Burgess and Davis introduce bipartisan bill aimed at enhancing the quality of care for individuals living with SCD through Medicaid  (WASHINGTON, February 29, 2024) – Congressional sickle cell disease (SCD) champions, Reps. Michael C...

Study suggests optimal therapy may differ for pre-existing versus new-onset hypertension (WASHINGTON, Feb. 5, 2024) – Combination treatments with two or more blood pressure drugs can significantly reduce blood pressure in patients taking ibrutinib, a...

(WASHINGTON, Feb. 1, 2024) — The American Society of Hematology (ASH) today announced the 36 recipients of its 2024 Scholar Awards. One of ASH’s most prestigious research award programs, the ASH Scholar Award supports early career investi...

(WASHINGTON, January 31, 2024) – The Centers for Medicare & Medicaid Innovation Center (CMMI) published the Cell & Gene Therapy (CGT) Access Model for Sickle Cell Disease, which aims to improve access to gene therapies treatments for people w...

(WASHINGTON, Jan. 9, 2024) — Mohandas Narla, DSc, distinguished scientist at New York Blood Center Enterprises, will serve as president of the American Society of Hematology (ASH) for a year-long term through December 2024.  Dr. Narla is...